Clinical Reference: Ayurvedic Management of PMOS (PCOS)
Reviewed by Dr. Megha Haldia, BAMS — Ayurvedic Physician, Qura Nutrition · Last reviewed: May 15, 2026 · Read our editorial policy
An overview of the Ayurvedic framework, herbal pharmacology, and clinical rationale behind the Trinaya PMOS (PCOS) protocol.
Program Positioning
The Trinaya Hormonal & Cycle wellness kit is designed as a lifestyle and wellness support program for women living with PMOS (PCOS). This formulation bridges traditional Ayurvedic lifestyle principles with contemporary understanding of general wellness, offering a comprehensive approach to daily routines, dietary patterns, and general wellness support that may complement standard medical care.
Understanding PMOS (PCOS): Beyond Symptoms
Modern Medical Perspective
What is PMOS (formerly PCOS)?
Polyendocrine Metabolic Ovarian Syndrome (PMOS) — formerly known as Polycystic Ovary Syndrome (PCOS) — affects approximately 1 in 8 women of reproductive age, or around 170 million women globally (Teede HJ et al., The Lancet, May 2026). The rename, adopted by global consensus and led by 50+ professional and patient organisations including the Endocrine Society, reflects the condition's multisystem nature: hormonal, metabolic, reproductive, dermatological, and psychological. The diagnostic criteria (Rotterdam, ESHRE/ASRM) remain unchanged. Characterised by:
Hormonal Imbalance
- Elevated androgens (testosterone, DHEA-S)
- Anti-Müllerian Hormone (AMH) elevation (Endocrine Society 2023 criteria; LH:FSH ratio is historically used but de-emphasized in current guidelines)
- Reduced luteal progesterone secondary to anovulatory cycles
Metabolic Dysfunction
- Insulin resistance (60-80% of cases)
- Compensatory hyperinsulinemia
- Impaired glucose metabolism
Reproductive Manifestations
- Anovulation or oligo-ovulation
- Irregular menstrual cycles (>35 days)
- Risk of endometrial hyperplasia from unopposed estrogen due to chronic anovulation
Pathological Cascade:
The Ayurvedic Understanding
PMOS (formerly PCOS) correlates with Artava Dushti (menstrual disorders) and Granthi (cystic formations).
Root Causes (Nidana):
Agnimandya (Digestive Fire Impairment)
- Compromised metabolism at cellular level
- Ama (metabolic toxin) accumulation
Kapha-Vata Avarana
- Kapha blocks Vata's movement
- Leads to follicular stagnation and cyst formation
Rasa-Rakta Dushti
- Vitiation of plasma and blood tissue
- Affects nutritional delivery to reproductive organs
Ayurvedic Framework:
“Both systems recognize that women living with PMOS (PCOS) may benefit from lifestyle approaches that support general wellness, including dietary patterns, daily routines, and general wellness support.”
Ayurvedic Root-Cause Approach
Samprapti Bhanga: Breaking the Pathological Chain
Four Action Pillars
Ayurvedic Action:
- Kindles digestive fire (Agni)
- Clears metabolic blockages (Ama)
Modern Correlation:
- Enhances insulin sensitivity
- Improves gut-mediated hormone metabolism
- Supports enterohepatic estrogen clearance
Key Herbs: Trikatu, Pippali, Chitraka
This pillar also includes Trijata — the classical three-spice compound (Cinnamomum verum, Elettaria cardamomum, Cinnamomum tamala). Cinnamon specifically has been studied in randomized controlled trials in PCOS, with documented improvements in menstrual cyclicity (Kort & Lobo, Am J Obstet Gynecol 2014) and insulin resistance (Hajimonfarednejad et al., Phytother Res 2018).
Ayurvedic Action:
- Scrapes excess Kapha and Meda (adipose tissue)
- Reduces pathological accumulations
Modern Correlation:
- Reduces visceral adiposity
- Modulates lipid metabolism
- Decreases androgen substrate availability
Key Herbs: Kanchanar, Saptarangi, Methi, Vijaysar
Ayurvedic Action:
- Nourishes reproductive tissue (Shukra Dhatu)
- Regulates Artava (menstrual flow)
- Supports Garbhashaya (uterine health)
Modern Correlation:
- Phytoestrogenic compounds may interact with reproductive hormone pathways (preliminary evidence)
- Classical use is in protocols for menstrual regularity (Artava regulation) and uterine tonification (Garbhashaya support)
- Direct clinical evidence in PMOS-specific endpoints is preliminary
Key Herbs: Shatavari, Shatapushpa, Ashoka, Lodhra
Ayurvedic Action:
- Cellular rejuvenation
- Stress adaptation (HPO-axis modulation)
- Ojas enhancement
Modern Correlation:
- Antioxidant activity demonstrated in preclinical models (animal and in-vitro)
- Cortisol-lowering effects in randomized trials of stressed adults (Ashwagandha); HPO-axis application is mechanistically inferential
- Preclinical mitochondrial supportive activity (Shilajit / fulvic acid); direct PMOS clinical evidence is limited
Key Herbs: Ashwagandha, Shilajit, Amalaki, Guduchi
“This comprehensive lifestyle approach supports general metabolic, hormonal, and tissue-level wellness through multiple pathways.”
Traditional Herbs Used in the Program
Stri Rasayana (female rejuvenative)
Contains phytoestrogenic shatavarin saponins traditionally used in Stri Rasayana protocols. Preclinical studies suggest modulation of reproductive hormone pathways; human clinical evidence is emerging.
Charaka Samhita, Chikitsa Sthana 1/1 (Brahma Rasayana)
Safety considerations
Caution in estrogen-sensitive conditions (breast, endometrial, ovarian cancers). Avoid in pregnancy unless under qualified supervision. Possible interactions with diuretics.
Lekhana, Granthi-nashana (anti-cystic)
Traditionally classified as Granthi-nashana in classical Ayurvedic texts. Flavonoid compounds demonstrate anti-inflammatory activity in preclinical models. Direct clinical trial evidence for ovarian endpoints in PMOS is limited.
Sushruta Samhita, Chikitsa Sthana 18 (Granthi-Apachi-Arbuda-Galaganda Chikitsa)
Safety considerations
Guggul component has documented interactions with warfarin, propranolol, diltiazem, and thyroid medications. Caution in hyperthyroidism. Avoid in pregnancy.
Balya Rasayana (adaptogenic tonic)
Withanolides demonstrate cortisol-lowering effects in randomized controlled trials of stressed adults (Salve 2019). Cortisol-related stress pathways are implicated in HPO-axis function; direct PCOS clinical evidence is preliminary.
Bhavaprakasha Nighantu, Guduchyadi Varga, verses 189-191
Safety considerations
Avoid in pregnancy. Caution in hyperthyroidism (may increase T4). Caution with sedatives and immunosuppressants. Avoid in autoimmune conditions without supervision.
Medohara (anti-adipose)
4-hydroxyisoleucine improves insulin signaling. Standardized fenugreek extracts have demonstrated efficacy in randomized controlled trials in PCOS, including reductions in ovarian cyst count, hirsutism, and improvements in menstrual regularity (Swaroop et al., 2015).
Bhavaprakasha Nighantu, Haritakyadi Varga
Swaroop et al., Int J Med Sci, 2015 (PMID 26516311) — RCT in 208 women with PCOS
Safety considerations
May potentiate hypoglycemic medications — monitor glucose closely. Avoid in pregnancy (uterine stimulant). Possible allergic cross-reactivity with chickpea, peanut. Caution with warfarin.
Rakta Shodhaka (blood purifier)
Curcumin demonstrates anti-inflammatory action through NF-κB pathway inhibition in preclinical models. A meta-analysis of 7 RCTs in PCOS (n=447) reported significant improvements in HOMA-IR, fasting glucose, insulin, and CRP.
Bhavaprakasha Nighantu, Haritakyadi Varga, verse 196
Sohaei et al., Front Endocrinol, 2022 (PMID 36387924) — meta-analysis of 7 RCTs, n=447
Safety considerations
Interactions with anticoagulants (warfarin, clopidogrel), antiplatelets, NSAIDs. May increase gallbladder contraction (caution in cholelithiasis). High doses may cause GI upset.
Pramehaghna (anti-diabetic)
Pterostilbene, marsupin, and epicatechin demonstrate insulin-sensitising activity. A multi-centre ICMR clinical trial in 97 patients with newly-diagnosed Type 2 Diabetes showed significant reductions in fasting and postprandial blood glucose over 12 weeks. Mechanistic overlap with PMOS-related insulin resistance is well established.
Bhavaprakasha Nighantu, Vatadi Varga
Safety considerations
May potentiate hypoglycaemic medications including metformin. Monitor blood glucose if used alongside antidiabetic therapy.
Rasayana, immunomodulator
Tinosporin and related compounds demonstrate immunomodulatory and anti-inflammatory activity in preclinical and clinical models. Direct evidence for estrogen metabolism modulation in PMOS is limited.
Charaka Samhita, Sutra Sthana 25/40 (Amritavalli)
Safety considerations
Rare cases of drug-induced liver injury reported with prolonged use. AYUSH Ministry has issued a hepatotoxicity advisory. Avoid in autoimmune conditions. Caution with immunosuppressants. NIH LiverTox reference: https://www.ncbi.nlm.nih.gov/books/NBK608429/
Balya, Yogavahi (bioenhancer)
Fulvic acid demonstrates mitochondrial supportive activity in preclinical models. Application to folliculogenesis is mechanistically inferential; direct clinical evidence in PMOS is limited. Purified per classical Shodhana protocol, NABL-tested for heavy metals (lead, mercury, arsenic, cadmium). Batch Certificate of Analysis available on request.
Bhavaprakasha Nighantu, Dhatu-upadhatu-Varga
Safety considerations
Used in this formulation is purified per Ayurvedic Shodhana protocol and lab-tested for heavy metals (lead, mercury, arsenic, cadmium). Avoid in pregnancy. Caution in hemochromatosis.
Stri Rasayana, Bhedana, Pittahara — used in Kumaryasava classical formulation for menstrual disorders
Anti-inflammatory polysaccharides and aloin-derived compounds. Demonstrated modulation of steroidogenic activity and metabolic-reproductive endpoints in letrozole-induced PCOS rodent models, with effects on lipid profile and ovarian function.
Bhavaprakasha Nighantu, Haritakyadi Varga; Kumaryasava (classical Aloe vera preparation)
Safety considerations
Contraindicated in pregnancy (uterine stimulant). Aloin-containing latex not recommended for long-term high-dose use. Our formulation uses purified leaf gel extract at 200mg per tablet in FLOW.
“Each herb is selected for its traditional use in supporting general wellness. These are dietary supplements for general wellness support only, not intended to diagnose, treat, cure, or prevent any disease.”
Where Ayurveda Meets Modern Science
Research Correlations
The Challenge:
60-80% of PMOS (formerly PCOS) patients exhibit insulin resistance, driving compensatory hyperinsulinemia → increased ovarian androgen production → anovulation.
Ayurvedic Strategy:
Medohara, Pramehaghna herbs (Methi, Vijaysar, Meshashringi, Jamun, Karela)
Mechanism:
- Enhance insulin receptor signaling
- Reduce hepatic gluconeogenesis
- Improve peripheral glucose uptake
- Lower postprandial glucose excursions
Clinical Relevance:
These Ayurvedic principles may support metabolic wellness as part of a broader clinical strategy. Medical treatment decisions remain the responsibility of licensed healthcare providers.
The Challenge:
Elevated free testosterone and DHEA-S → hirsutism, acne, seborrhea, and inhibition of follicular maturation.
Ayurvedic Strategy:
Rakta Shodhaka, anti-inflammatory herbs (Haridra, Neem, Manjishta) + insulin modulators
Mechanism:
- Reduce hyperinsulinemia (primary androgen driver)
- Anti-inflammatory action on ovarian theca cells
- Support hepatic androgen clearance
- Phytoestrogens provide negative feedback
Clinical Relevance:
These formulations are intended as supportive care and should be considered alongside standard reproductive health management.
The Challenge:
Arrested follicular development, anovulation, inadequate corpus luteum formation → irregular cycles, infertility.
Ayurvedic Strategy:
Artava-janana, Garbhashaya tonic herbs (Shatavari, Shatapushpa, Ulatkambal, Lodhra)
Mechanism:
- Phytoestrogenic support for follicular recruitment
- Improved pelvic microcirculation
- Luteal phase progesterone support
Clinical Relevance:
Dietary and lifestyle modifications should be individualised in consultation with the patient's primary care team.
The Challenge:
Oligomenorrhea/amenorrhea → endometrial hyperplasia risk, unpredictable bleeding, fertility challenges.
Ayurvedic Strategy:
Artava regulator herbs (Manjishta, Ashoka, Kumari, Dashmool) + iron support (Pomegranate, Moringa)
Mechanism:
- Supports endometrial vascularization
- Optimizes estrogen-progesterone balance
- Anti-inflammatory action reduces menstrual pain
- Nutritional support for tissue health
Clinical Relevance:
Herbal supplementation should be reviewed for interactions with concurrent pharmaceutical treatment.
Evidence Base
Classical Ayurvedic Texts:
- • Charaka Samhita (Chikitsa Sthana: Yonivyapad, Rasayana)
- • Sushruta Samhita (Chikitsa Sthana)
- • Bhavaprakasha Nighantu (classical text — see citation notes per herb above)
- • Ashtanga Hridaya
Selected peer-reviewed references
- • Pandey et al., Biomed Pharmacother 2018 — Shatavari (stress & female reproductive health)
- • Misra et al., Ayurvedic Approaches to PCOS Management — Kanchanar (PMC11805180)
- • Salve et al., Cureus 2019 (PMID 31728244) — Ashwagandha cortisol RCT
- • Swaroop et al., Int J Med Sci 2015 (PMID 26516311) — Methi Furocyst PCOS RCT, n=208
- • Sohaei et al., Front Endocrinol 2022 (PMID 36387924) — Haridra/curcumin PCOS meta-analysis, 7 RCTs, n=447
- • ICMR Multi-centre Trial, Indian J Med Res 1998 — Vijaysar (Pterocarpus marsupium, n=97 T2DM)
- • Tinospora cordifolia in PCOS, 2023 — Guduchi (insulin resistance, lipid profile, glucose metabolism)
- • Carrasco-Gallardo et al., fulvic acid mechanism (PMID 26395129) — Shilajit
- • Aloe barbadensis in PCOS, J Ethnopharmacol 2022 — Aloevera (Kumari) steroidogenic & metabolic endpoints
“This program bridges traditional lifestyle wisdom with contemporary understanding of general wellness principles for women living with PMOS (PCOS).”
Common Questions from Referring Clinicians
What is the new name for PCOS?+
In May 2026, a global consensus published in The Lancet renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The diagnostic criteria are unchanged; the new name reflects the condition’s multisystem nature. We use PMOS with PCOS in parentheses for continuity.
How does Qura’s Ayurvedic protocol integrate with metformin or hormonal therapy?+
Concurrent use with metformin is generally well-tolerated; we recommend close glucose monitoring during the first 4–6 weeks. With combined oral contraceptives there are no major documented interactions, though phytoestrogens (Shatavari) should be reviewed case-by-case. We do not advise discontinuing prescribed pharmacotherapy.
What contraindications should I screen for before recommending?+
Pregnancy (Ashwagandha, Methi, Kanchanar Guggulu are contraindicated), concurrent anticoagulants (Haridra, Methi interactions), hyperthyroidism (Ashwagandha, Kanchanar Guggulu), estrogen-sensitive cancers (Shatavari), autoimmune conditions (Guduchi, Ashwagandha), and known sensitivities to fenugreek/peanut/chickpea (Methi). A full per-herb safety profile is in the herb pharmacology section above.
Are heavy metal test reports available?+
Yes. Each batch is NABL-tested for lead, mercury, arsenic, and cadmium. Batch-specific Certificates of Analysis are available on request to healthcare professionals.
How do I refer a patient to your program?+
Patients can self-enroll via our 3-Month PMOS Cycle Program page. For clinician referrals or to discuss integration with your treatment plan, contact our Ayurvedic medical team via the clinical enquiry line below.
What outcomes data do you have?+
We are currently compiling a structured outcomes summary from our patient cohort. For specific endpoints or case discussions, please contact Dr. Megha directly.
How are your formulations regulated?+
The Trinaya Hormonal & Cycle wellness kit is an AYUSH-approved Ayurvedic formulation, manufactured in a GMP-certified Ayurvedic facility and lab-tested by NABL-accredited laboratories for purity, potency, and heavy metal limits. The formulations follow classical Ayurvedic pharmacopoeial standards. AYUSH licensing details are available to healthcare professionals on request.
Clinical Enquiries: Healthcare Professionals (India)
www.quranutrition.com | hello@quranutrition.com
💬 WhatsApp Clinical Enquiry Line: +91 8209037925 (Mon–Sat, 9 AM–6 PM IST)